PNC Financial Services Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35K | Sell |
7,544
-377
| -5% | -$167 | ﹤0.01% | 4257 |
|
|
2025
Q1 | $4.48K | Buy |
7,921
+2,742
| +53% | +$1.55K | ﹤0.01% | 4103 |
|
|
2024
Q4 | $10.9K | Buy |
5,179
+5,125
| +9,491% | +$10.8K | ﹤0.01% | 3773 |
|
|
2024
Q3 | $145 | Hold |
54
| – | – | ﹤0.01% | 4702 |
|
|
2024
Q2 | $154 | Buy |
+54
| New | +$154 | ﹤0.01% | 4696 |
|
|
2024
Q1 | – | Sell |
-22
| Closed | -$118 | – | 4742 |
|
|
2023
Q4 | $118 | Buy |
+22
| New | +$118 | ﹤0.01% | 4511 |
|
|
2018
Q3 | – | Sell |
-152
| Closed | -$1K | – | 4169 |
|
|
2018
Q2 | $1K | Sell |
152
-3,385
| -96% | -$22.3K | ﹤0.01% | 4057 |
|
|
2018
Q1 | $18K | Hold |
3,537
| – | – | ﹤0.01% | 3484 |
|
|
2017
Q4 | $12K | Hold |
3,537
| – | – | ﹤0.01% | 3622 |
|
|
2017
Q3 | $13K | Buy |
+3,537
| New | +$13K | ﹤0.01% | 3579 |
|
|
2014
Q4 | – | Sell |
-400
| Closed | -$2K | – | 4190 |
|
|
2014
Q3 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 3661 |
|